R. Bianco

1.0k total citations
43 papers, 778 citations indexed

About

R. Bianco is a scholar working on Hematology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, R. Bianco has authored 43 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 10 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in R. Bianco's work include Hemophilia Treatment and Research (18 papers), Platelet Disorders and Treatments (9 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). R. Bianco is often cited by papers focused on Hemophilia Treatment and Research (18 papers), Platelet Disorders and Treatments (9 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). R. Bianco collaborates with scholars based in Argentina, Italy and Romania. R. Bianco's co-authors include L. Rusen, Liselotte S. Ebbesen, M. Şerban, Barbara A. Konkle, Toshko Lissitchkov, Elisabeth Erhardtsen, Margherita Silengo, P Franceschini, M. Biagioli and M.A. Lazzari and has published in prestigious journals such as Blood, Annals of Oncology and European Journal of Cancer.

In The Last Decade

R. Bianco

43 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Bianco Argentina 16 521 166 145 86 85 43 778
Katja Hofer Austria 13 226 0.4× 148 0.9× 132 0.9× 83 1.0× 73 0.9× 17 671
Sou‐Ming Chuang Taiwan 15 212 0.4× 114 0.7× 160 1.1× 109 1.3× 47 0.6× 25 681
Hélène Trebeden‐Negre France 14 165 0.3× 94 0.6× 94 0.6× 43 0.5× 55 0.6× 19 544
M. Alcorn United Kingdom 14 420 0.8× 131 0.8× 139 1.0× 15 0.2× 130 1.5× 23 678
Futoshi Hashimoto Japan 8 147 0.3× 104 0.6× 105 0.7× 28 0.3× 41 0.5× 10 502
L Markling Sweden 13 310 0.6× 72 0.4× 148 1.0× 14 0.2× 51 0.6× 28 616
Moreno Festuccia Italy 15 324 0.6× 153 0.9× 58 0.4× 30 0.3× 20 0.2× 34 529
Dvora Sahar Israel 9 63 0.1× 96 0.6× 98 0.7× 103 1.2× 20 0.2× 19 415
G Tricot United States 8 298 0.6× 145 0.9× 50 0.3× 13 0.2× 47 0.6× 21 550
Masuko Tagawa Japan 12 196 0.4× 97 0.6× 114 0.8× 25 0.3× 14 0.2× 26 523

Countries citing papers authored by R. Bianco

Since Specialization
Citations

This map shows the geographic impact of R. Bianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Bianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Bianco more than expected).

Fields of papers citing papers by R. Bianco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Bianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Bianco. The network helps show where R. Bianco may publish in the future.

Co-authorship network of co-authors of R. Bianco

This figure shows the co-authorship network connecting the top 25 collaborators of R. Bianco. A scholar is included among the top collaborators of R. Bianco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Bianco. R. Bianco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bianco, R., et al.. (2025). Implementing Oncologic Nursing Care Plans in Electronic Health Records With Two Taxonomies: A Pilot Study. Western Journal of Nursing Research. 47(3). 159–168. 1 indexed citations
2.
Formisano, Luigi, Roberta Marciano, Anna Chiara Carratù, et al.. (2019). FOLFIRINOX after first-line gemcitabine-based chemotherapy in metastatic pancreatic cancer: a mono-institutional experience. Annals of Oncology. 30. iv52–iv53. 1 indexed citations
3.
Rossetti, Liliana Carmen, R. Bianco, Irene Larripa, et al.. (2012). Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B. Thrombosis and Haemostasis. 109(1). 24–33. 31 indexed citations
5.
Candela, M., et al.. (2011). Severe haemophilia A patients have reduced numbers of peripheral memory B cells. Haemophilia. 18(3). 437–443. 3 indexed citations
6.
Bianco, R., et al.. (2010). Secondary prophylaxis with rFVIIa in hemophilia and inhibitors: recommendations from an experts committee from Argentina.. PubMed. 70(3). 209–14. 1 indexed citations
7.
Candela, M., et al.. (2010). A flow cytometry evaluation of anti-FVIII antibodies: correlation with ELISA and Bethesda assay. Haemophilia. 17(2). 267–274. 9 indexed citations
8.
Bianco, R., Margareth C. Ozelo, Paula Ribeiro Villaça, et al.. (2008). Diagnosis and treatment of congenital hemophilia with inhibitors a Latin American perspective.. PubMed. 68(3). 227–42. 18 indexed citations
9.
Bianco, R., et al.. (2007). Haemophilic pseudotumour of the mandible: report of three cases. International Journal of Oral and Maxillofacial Surgery. 36(6). 552–555. 19 indexed citations
10.
Konkle, Barbara A., Liselotte S. Ebbesen, Elisabeth Erhardtsen, et al.. (2007). Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors. Journal of Thrombosis and Haemostasis. 5(9). 1904–1913. 259 indexed citations
11.
Rossetti, Liliana Carmen, Claudia Pamela Radic, M. Candela, et al.. (2007). Sixteen novel hemophilia A causative mutations in the first Argentinian series of severe molecular defects. Haematologica. 92(6). 842–845. 21 indexed citations
12.
Srivastava, Alok, Yasmin Ayob, Ampaiwan Chuansumrit, et al.. (2005). Hemophilia Treatment in Developing Countries: Products and Protocols. Seminars in Thrombosis and Hemostasis. 31(5). 495–500. 25 indexed citations
13.
Rossetti, Liliana Carmen, et al.. (2004). Analysis of factor VIII gene intron 1 inversion in Argentinian families with severe haemophilia A and a review of the literature. Blood Coagulation & Fibrinolysis. 15(7). 569–572. 19 indexed citations
14.
Bianco, R., et al.. (2003). Structural aberrations of chromosomes 17 and 12 in chronic B‐cell disorders. European Journal Of Haematology. 71(6). 433–438. 2 indexed citations
16.
Massud, Ivana, et al.. (2002). [Prevalence of hepatitis G virus infection in a cohort of hemophilic HIV positive patients].. PubMed. 62(2). 173–5. 5 indexed citations
17.
Belmonte, Liliana, et al.. (2001). Monocyte Differentiation and HIV Replication after Prolonged Culture of Peripheral Blood Mononuclear Cells from HIV-Infected Individuals. Cellular Immunology. 210(1). 11–20. 11 indexed citations
18.
Blanco, A, et al.. (1997). Anti-factor VIII Inhibitors and Lupus Anticoagulants in Haemophilia A Patients. Thrombosis and Haemostasis. 77(4). 656–659. 24 indexed citations
19.
Silengo, Margherita, R. Bianco, M. Biagioli, et al.. (1984). Interstitial deletion of chromosome 1 (q23–25). Report of a case. Clinical Genetics. 25(6). 549–552. 14 indexed citations
20.
Silengo, Margherita, et al.. (1983). Kniest disease with Pierre Robin syndrome and hydrocephalus. Pediatric Radiology. 13(2). 106–109. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026